Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, September 1, 2023
[ Fri, Sep 01st 2023
] - WOPRAI
[ Fri, Sep 01st 2023
] - WOPRAI
[ Fri, Sep 01st 2023
] - WOPRAI
[ Fri, Sep 01st 2023
] - WOPRAI
[ Fri, Sep 01st 2023
] - WOPRAI
[ Fri, Sep 01st 2023
] - WOPRAI
[ Fri, Sep 01st 2023
] - WOPRAI
[ Fri, Sep 01st 2023
] - WOPRAI
[ Fri, Sep 01st 2023
] - WOPRAI
[ Fri, Sep 01st 2023
] - WOPRAI
[ Fri, Sep 01st 2023
] - WOPRAI
[ Fri, Sep 01st 2023
] - WOPRAI
[ Fri, Sep 01st 2023
] - WOPRAI
[ Fri, Sep 01st 2023
] - WOPRAI
[ Fri, Sep 01st 2023
] - WOPRAI
[ Fri, Sep 01st 2023
] - WOPRAI
[ Fri, Sep 01st 2023
] - WOPRAI
[ Fri, Sep 01st 2023
] - WOPRAI
[ Fri, Sep 01st 2023
] - WOPRAI
[ Fri, Sep 01st 2023
] - WOPRAI
[ Fri, Sep 01st 2023
] - WOPRAI
[ Fri, Sep 01st 2023
] - WOPRAI
[ Fri, Sep 01st 2023
] - WOPRAI
[ Fri, Sep 01st 2023
] - WOPRAI
[ Fri, Sep 01st 2023
] - WOPRAI
[ Fri, Sep 01st 2023
] - WOPRAI
[ Fri, Sep 01st 2023
] - WOPRAI
[ Fri, Sep 01st 2023
] - WOPRAI
[ Fri, Sep 01st 2023
] - WOPRAI
[ Fri, Sep 01st 2023
] - WOPRAI
Edward Nash Reiterated (VRNA) at Strong Buy and Held Target at $35 on, Sep 1st, 2023
Edward Nash of Canaccord Genuity, Reiterated "Verona Pharma plc" (VRNA) at Strong Buy and Held Target at $35 on, Sep 1st, 2023.
Edward has made no other calls on VRNA in the last 4 months.
There are 3 other peers that have a rating on VRNA. Out of the 3 peers that are also analyzing VRNA, 0 agree with Edward's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Edward
- Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $32 on, Friday, August 4th, 2023
- Liana Moussatos of "Wedbush" Reiterated at Buy and Held Target at $30 on, Wednesday, June 28th, 2023
- Joon Lee of "Truist Securities" Reiterated at Strong Buy and Held Target at $32 on, Tuesday, June 27th, 2023
